The global biopharmaceutical CMO and CRO market was valued at USD 54.12 billion in 2030 and is anticipated to grow at a CAGR of 5.6% from 2024 to 2030 according to a new study by Grand View Research, Inc.. Post-pandemic the market is being driven by the growing interest of conventional drug developers in the biological therapeutics. At present, outsourcing has become a cost-saving...